Nationwide Fund Advisors increased its stake in NanoString Technologies, Inc. (NASDAQ:NSTG) by 368.4% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 41,098 shares of the biotechnology company’s stock after acquiring an additional 32,323 shares during the quarter. Nationwide Fund Advisors owned 0.19% of NanoString Technologies worth $680,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its stake in shares of NanoString Technologies by 2.7% in the 1st quarter. Vanguard Group Inc. now owns 588,558 shares of the biotechnology company’s stock valued at $11,695,000 after acquiring an additional 15,343 shares in the last quarter. Russell Investments Group Ltd. increased its stake in shares of NanoString Technologies by 1,452.0% in the 2nd quarter. Russell Investments Group Ltd. now owns 538,792 shares of the biotechnology company’s stock valued at $8,910,000 after acquiring an additional 504,075 shares in the last quarter. RE Advisers Corp increased its stake in shares of NanoString Technologies by 5.9% in the 2nd quarter. RE Advisers Corp now owns 521,132 shares of the biotechnology company’s stock valued at $8,620,000 after acquiring an additional 29,132 shares in the last quarter. Wellington Management Group LLP increased its stake in shares of NanoString Technologies by 6.8% in the 1st quarter. Wellington Management Group LLP now owns 509,051 shares of the biotechnology company’s stock valued at $10,115,000 after acquiring an additional 32,541 shares in the last quarter. Finally, Renaissance Technologies LLC increased its stake in shares of NanoString Technologies by 45.7% in the 1st quarter. Renaissance Technologies LLC now owns 350,000 shares of the biotechnology company’s stock valued at $6,955,000 after acquiring an additional 109,800 shares in the last quarter. Institutional investors own 93.04% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This story was posted by TheOlympiaReport and is owned by of TheOlympiaReport. If you are viewing this story on another publication, it was illegally stolen and republished in violation of U.S. & international trademark & copyright law. The correct version of this story can be viewed at https://theolympiareport.com/2017/10/31/nanostring-technologies-inc-nstg-shares-bought-by-nationwide-fund-advisors.html.

Shares of NanoString Technologies, Inc. (NASDAQ NSTG) opened at 9.72 on Tuesday. The company’s market cap is $244.98 million. NanoString Technologies, Inc. has a 52 week low of $9.05 and a 52 week high of $23.45. The firm’s 50-day moving average is $13.88 and its 200-day moving average is $15.72.

NanoString Technologies (NASDAQ:NSTG) last announced its quarterly earnings data on Tuesday, August 8th. The biotechnology company reported ($0.20) EPS for the quarter, beating the consensus estimate of ($0.37) by $0.17. The business had revenue of $34.59 million during the quarter, compared to analyst estimates of $29.87 million. NanoString Technologies had a negative return on equity of 329.59% and a negative net margin of 44.28%. Equities research analysts predict that NanoString Technologies, Inc. will post ($2.26) earnings per share for the current year.

Several analysts have recently weighed in on NSTG shares. Zacks Investment Research lowered shares of NanoString Technologies from a “hold” rating to a “sell” rating in a research note on Tuesday, October 17th. Cowen and Company reiterated a “buy” rating and issued a $20.00 price objective on shares of NanoString Technologies in a research note on Thursday, September 28th. Robert W. Baird lowered their price objective on shares of NanoString Technologies from $23.00 to $19.00 and set an “outperform” rating for the company in a research note on Thursday, October 12th. Janney Montgomery Scott lowered shares of NanoString Technologies from a “buy” rating to a “neutral” rating in a research note on Thursday, October 12th. Finally, BidaskClub lowered shares of NanoString Technologies from a “hold” rating to a “sell” rating in a research note on Sunday, July 16th. Three analysts have rated the stock with a sell rating, three have issued a hold rating and one has given a buy rating to the stock. The company has an average rating of “Hold” and an average target price of $17.75.

About NanoString Technologies

NanoString Technologies, Inc develops, manufactures and sells intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue. The Company is engaged in the development, manufacture and commercialization of instruments, consumables and services for profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample.

Institutional Ownership by Quarter for NanoString Technologies (NASDAQ:NSTG)

Receive News & Ratings for NanoString Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.